Sheng‐Hao Lin

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients

Bing‐Yen Wang, Jing‐Yang Huang, Heng‐Chung Chen et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 262 citations · Full text

Medicine, Oncology, Surgery +14

Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy

J. L. Guerra, Daniel R. Gomez, Sheng‐Hao Lin et al. · Annals of Oncology · 2012 · 73 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population‐based study

Charles Tzu‐Chi Lee, I‐Chieh Mao, Ching‐Hsiung Lin et al. · European Journal of Clinical Investigation · 2013 · 61 citations

Medicine, Health Sciences, Internal Medicine +12

Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease

Chew‐Teng Kor, Yi‐Rong Li, Pei‐Ru Lin et al. · Journal of Personalized Medicine · 2022 · 53 citations · Full text

Computing, Data Science, Health Informatics +17